Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome
Martine E.D. Chamuleau(Hovon), Arjan A. van de Loosdrecht(Dutch Cancer Society), Theresia M. Westers(Vrije Universiteit Amsterdam), Corien Eeltink(Vrije Universiteit Amsterdam), L. van Dreunen(Amsterdam UMC Location VUmc), J. Groenland(Amsterdam UMC Location VUmc), Adri Zevenbergen(Amsterdam UMC Location VUmc), G. J. Ossenkoppele(Amsterdam UMC Location VUmc)
Cited by 72
Related Papers
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633